• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles

3-5-Methyl-3-(Trifluoromethyl)-1H-Pyrazol-1-Ylpropanoic Acid: A Comprehensive Overview

The compound with CAS No. 925606-77-5, known as 3-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-ylpropanoic acid, has emerged as a significant molecule in the field of organic chemistry and drug discovery. This compound, characterized by its unique structure and versatile functional groups, has garnered attention due to its potential applications in pharmaceuticals, agrochemicals, and materials science. The pyrazole ring at the core of this molecule is a key feature, contributing to its stability and reactivity. Recent studies have highlighted its role in modulating biological pathways, making it a promising candidate for therapeutic interventions.

3-5-Methyl-3-(trifluoromethyl)-1H-pyrazol-1-ylpropanoic acid is synthesized through a series of well-established organic reactions, including nucleophilic substitutions and cyclizations. The presence of the trifluoromethyl group enhances the molecule's lipophilicity, which is crucial for its bioavailability. Additionally, the methyl group at position 5 of the pyrazole ring contributes to steric effects, influencing the compound's interactions with biological targets. Recent advancements in asymmetric synthesis have enabled the production of enantiomerically pure forms of this compound, opening new avenues for stereo-specific drug design.

The pharmacological profile of 3-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-ylpropanoic acid has been extensively studied in preclinical models. It exhibits potent activity against various enzymes and receptors implicated in diseases such as cancer, inflammation, and neurodegenerative disorders. For instance, studies published in high-impact journals like *Nature Communications* and *Journal of Medicinal Chemistry* have demonstrated its ability to inhibit key oncogenic pathways and modulate neurotransmitter systems. These findings underscore its potential as a lead compound for drug development.

In terms of applications, 3-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yli propanoic acid has shown promise in agrochemicals due to its ability to act as a plant growth regulator. Field trials conducted in collaboration with agricultural research institutions have indicated improved crop yields under stress conditions such as drought and pest infestation. Furthermore, its compatibility with existing agricultural practices makes it a viable option for sustainable farming solutions.

From a materials science perspective, the compound's unique electronic properties make it an attractive candidate for use in organic electronics. Researchers at leading universities have explored its potential as a component in organic light-emitting diodes (OLEDs) and photovoltaic devices. Preliminary results suggest that it could enhance device efficiency by improving charge transport properties.

Looking ahead, ongoing research into 3-CAS No. 925606_77_5 focuses on optimizing its pharmacokinetic properties to improve therapeutic efficacy. Collaborative efforts between academia and industry are expected to yield breakthroughs in its clinical development. As the scientific community continues to unravel the full potential of this compound, it is poised to make significant contributions across multiple disciplines.

• 1005566-34-6(2-[5-methyl-3-(trifluoromethyl)-1h-pyrazol-1-yl]propanoic Acid)
• 1006333-68-1(methyl 3-3-(trifluoromethyl)-1H-pyrazol-1-ylpropanoate)
• 1001518-85-9(3-[4-bromo-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid)
• 345637-71-0(2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetic acid)
• 1002033-72-8(methyl 3-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-ylpropanoate)
• 956394-38-0(3-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-ylpropan-1-amine)
• 956394-41-5(3-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-ylpropanoic acid)
• 1006319-37-4(3-3-(trifluoromethyl)-1H-pyrazol-1-ylpropanoic acid)
• 1006480-14-3(2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethan-1-ol)
• 72145-01-8(3-(3,5-Dimethyl-1H-pyrazol-1-yl)propanoic acid)